Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-006395
Filing Date
2008-08-12
Accepted
2008-08-12 17:12:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. g06286b4sv1za.htm S-1/A 2039686
2 EX-10.7 DISTRIBUTION SERVICES AGREEMENT g06286b4exv10w7.htm EX-10.7 85701
3 EX-10.9.2 SECOND AMENDMENT TO KRISTALOSE AGREEMENT g06286b4exv10w9w2.htm EX-10.9.2 7444
4 EX-10.26 EMPLOYMENT AGREEMENT EFFECTIVE AS OF JULY 1, 2008 BY AND BETWEEN MARTIN g06286b4exv10w26.htm EX-10.26 25734
5 EX-23.1 CONSENT OF KPMG LLP g06286b4exv23w1.htm EX-23.1 2678
6 EX-23.3 CONSENT OF MORGAN JOSEPH & CO, INC. g06286b4exv23w3.htm EX-23.3 3031
7 GRAPHIC g06286b4g0628602.gif GRAPHIC 3768
8 GRAPHIC g06286b4g0628600.gif GRAPHIC 5123
9 GRAPHIC g06286b4g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-08-006395.txt   2178805
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 081010496
SIC: 2834 Pharmaceutical Preparations